Elsevier logo

Publisher: Elsevier

Volume 23, Number 6, June 2001
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial comment
pp. 771-771(1)
Author: Walson P.D.

Current options for the prevention and treatment of migraine
pp. 772-788(17)
Authors: Adelman J.U.; Adelman R.D.

Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid
pp. 789-801(13)
Authors: Pavlatos A.M.; Fultz O.; Monberg M.J.; Vootkur A.

Entacapone: A catechol-O-methyltransferase inhibitor for the adjunctive treatment of parkinson's disease
pp. 802-832(31)
Author: Najib J.

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial
pp. 833-850(18)
Authors: McGill J.B.; Reilly P.A.

Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia
pp. 851-857(7)
Authors: Branchi A.; Fiorenza A.M.; Torri A.; Muzio F.; Berra C.; Colombo E.; Valle E.D.; Rovellini A.; Sommariva D.

STATT: a titrate-to-goal study of simvastatin in asian patients with coronary heart disease
pp. 858-870(13)
Authors: Chung N.; Cho S.-Y.; Choi D.-H.; Zhu J.-R.; Lee K.; Lee P.-Y.; Lee S.-H.; Lee S.; Wang J.-J.; Yin W.-H.; Young M.-S.; Koh K.-K.; Son J.-W.; Sangwatanaroj S.; Panchavinnin P.; Phankingthongkum R.; Cai N.-S.; Fan W.-F.

A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe
pp. 871-885(15)
Authors: Ezzet F.; Krishna G.; Wexler D.B.; Statkevich P.; Kosoglou T.; Batra V.K.

Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study
pp. 886-900(15)
Authors: Solomon S.; Frishberg B.; Hu X.H.; Markson L.; Berger M.

A comparison of the skin permeation of three topical 0.5 0.000000luorouracil formulations with that of a 5 816242119941358331629659989308000000000000000.000000ormulation
pp. 901-907(7)
Authors: Levy S.; Furst K.; Chern W.

A pharmacokinetic evaluation of 0.5and 5 0.000000luorouracil topical cream in patients with actinic keratosis
pp. 908-920(13)
Authors: Levy S.; Furst K.; Chern W.

Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin
pp. 921-931(11)
Authors: Zussman B.D.; Kelly J.; Murdoch R.D.; Clark D.J.; Schubert C.; Collie H.

Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting
pp. 932-938(7)
Author: Walker J.B.

Enhancing the benefits of pharmaceuticals: what should states do?
pp. 940-941(2)
Author: Lyles A.

Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach
pp. 942-956(15)
Authors: Sauriol L.; Laporta M.; Edwardes M.D.; Deslandes M.; Ricard N.; Suissa S.

Responsiveness of the smoking cessation quality of life (SCQoL) questionnaire
pp. 957-969(13)
Authors: Shaw J.W.; Coons S.J.; Foster S.A.; Leischow S.J.; Hays R.D.

The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the First Myocardial Infarction Risk Reduction Program
pp. 970-980(11)
Author: Guthrie R.M.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A